{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:15:33Z","timestamp":1769220933665,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008973","name":"University of Kurdistan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.micpath.2025.107613","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T19:25:26Z","timestamp":1744917926000},"page":"107613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Investigation of the inhibitory effects of immunoglobulin Y antibody against key epitopes of Helicobacter pylori UreB recombinant protein"],"prefix":"10.1016","volume":"204","author":[{"given":"Zahra","family":"Esmaeili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Kamal Shahsavar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Ariannejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Hajinajaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaho","family":"Menbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiarash","family":"Ghazvini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2025.107613_bib1","first-page":"12267","article-title":"Helicobacter pylori and skin disorders: a comprehensive review of the available literature","volume":"24","author":"Guarneri","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.micpath.2025.107613_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12403","article-title":"Pathogenesis of Helicobacter pylori infection","volume":"22","author":"Burucoa","year":"2017","journal-title":"Helicobacter"},{"key":"10.1016\/j.micpath.2025.107613_bib3","series-title":"Gastric Cancer","first-page":"31","article-title":"Helicobacter pylori and related virulence factors for gastrointestinal diseases","author":"Kabamba","year":"2019"},{"key":"10.1016\/j.micpath.2025.107613_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2017.02.026","article-title":"Helicobacter pylori virulence factors in relation to gastrointestinal diseases in Iran","author":"Safaralizadeh","year":"2017","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2025.107613_bib5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S2468-1253(23)00070-5","article-title":"Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis","volume":"8","author":"Li","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.micpath.2025.107613_bib6","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.micpath.2025.107613_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2022-327745","article-title":"European Helicobacter and Microbiota Study group, Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.micpath.2025.107613_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13067","article-title":"Oral immunotherapy for Helicobacter pylori: can it be trusted? A systematic review","volume":"29","author":"Peypar","year":"2024","journal-title":"Helicobacter"},{"key":"10.1016\/j.micpath.2025.107613_bib9","author":"FitzGerald"},{"key":"10.1016\/j.micpath.2025.107613_bib10","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.3389\/fmicb.2018.03158","article-title":"Principles of immunotherapy: implications for treatment strategies in cancer and infectious diseases","volume":"9","author":"Naran","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2025.107613_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S1466252315000195","article-title":"Passive immunization with hyperimmune egg-yolk IgY as prophylaxis and therapy for poultry diseases-A review","volume":"16","author":"Gadde","year":"2015","journal-title":"Anim. Health Res. Rev."},{"key":"10.1016\/j.micpath.2025.107613_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.molimm.2024.07.002","article-title":"Evaluation of the prophylactic effect of egg yolk antibody (IgY) produced against the recombinant protein containing IpaD, IpaB, StxB, and VirG proteins from Shigella","volume":"173","author":"Felegary","year":"2024","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.micpath.2025.107613_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39650","article-title":"Therapeutic efficacy of SipD\/LptD-specific IgY entrapped in alginate nanoparticles against Salmonella Typhimurium infection","volume":"10","author":"Zafarmand-Samarin","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.micpath.2025.107613_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2024.115062","article-title":"Development of polyclonal chicken egg yolk immunoglobulin Y (IgY) antibodies targeting SARS-CoV-2 multi-epitope antigen","volume":"331","author":"Fibriani","year":"2025","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.micpath.2025.107613_bib15","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1186\/s12879-024-09498-4","article-title":"Real-world evidence of a novel tetravalent immunoglobulin Y effectiveness and safety in patients with the refractory Helicobacter pylori infection","volume":"24","author":"Hao","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107613_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1065353","article-title":"IgY antibodies: the promising potential to overcome antibiotic resistance","volume":"14","author":"El-Kafrawy","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2025.107613_bib17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/21645515.2018.1514224","article-title":"IgY antibodies for the immunoprophylaxis and therapy of respiratory infections","volume":"15","author":"Abbas","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.micpath.2025.107613_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12843","article-title":"Dietary multivalent anti-Helicobacter pylori immunoglobulin Y significantly increase the H. pylori eradication and improve the clinical symptoms in patients","volume":"26","author":"Guo","year":"2021","journal-title":"Helicobacter"},{"key":"10.1016\/j.micpath.2025.107613_bib19","doi-asserted-by":"crossref","first-page":"13691","DOI":"10.1021\/acs.jafc.1c05398","article-title":"Potential therapeutic effects of egg yolk antibody (IgY) in Helicobacter pylori Infections\u2500A review","volume":"69","author":"Zhang","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.micpath.2025.107613_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1464484","article-title":"The effect of three urease inhibitors on H. pylori viability, urease activity and urease gene expression","volume":"15","author":"Shaalan","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2025.107613_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12807","article-title":"Oral multivalent epitope vaccine, based on UreB, HpaA, CAT, and LTB, for prevention and treatment of Helicobacter pylori infection in C57BL\/6 mice","volume":"26","author":"Xie","year":"2021","journal-title":"Helicobacter"},{"key":"10.1016\/j.micpath.2025.107613_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femspd\/ftu018","article-title":"Protection against Helicobacter pylori infection in BALB\/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB","volume":"73","author":"Yang","year":"2015","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.micpath.2025.107613_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1099\/jmm.0.05327-0","article-title":"Production of anti-Helicobacter pylori urease-specific immunoglobulin in egg yolk using an antigenic epitope of H. pylori urease","volume":"53","author":"Shin","year":"2004","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2025.107613_bib24","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1016\/j.vaccine.2019.04.045","article-title":"Synergistic effect of anti-Helicobacter pylori urease immunoglobulin Y from egg yolk of immunized hens and Lactobacillus johnsonii No.1088 to inhibit the growth of Helicobacter pylori in vitro and in vivo","volume":"37","author":"Aiba","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2025.107613_bib25","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1080\/09540105.2019.1617251","article-title":"Anti-urease immunoglobulin (IgY) from egg yolk prevents Helicobacter pylori infection in a mouse model","volume":"30","author":"Mony","year":"2019","journal-title":"Food Agric. Immunol."},{"key":"10.1016\/j.micpath.2025.107613_bib26","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1128\/iai.59.7.2470-2475.1991","article-title":"Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets","volume":"59","author":"Eaton","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2025.107613_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2017.00349","article-title":"Oral Immunization with a multivalent epitope-based vaccine, based on NAP, Urease, HSP60, and HpaA, provides therapeutic effect on H. pylori infection in Mongolian gerbils","volume":"7","author":"Guo","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2025.107613_bib28","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1016\/j.vaccine.2010.05.067","article-title":"Identification of B-cell epitopes in urease B subunit of Helicobacter pylori bound by neutralizing antibodies","volume":"28","author":"Qiu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2025.107613_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12959","article-title":"UreB immunodominant epitope-specific CD8+ T-cell responses were beneficial in reducing gastric symptoms in Helicobacter pylori-infected individuals","volume":"28","author":"He","year":"2023","journal-title":"Helicobacter"},{"key":"10.1016\/j.micpath.2025.107613_bib30","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1016\/j.vaccine.2008.09.089","article-title":"Screening and identification of a novel B-cell neutralizing epitope from Helicobacter pylori UreB","volume":"26","author":"Li","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2025.107613_bib31","first-page":"1","article-title":"Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB\/c mice","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2025.107613_bib32","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1007\/s00253-013-5408-6","article-title":"Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB\/c mice model","volume":"98","author":"Guo","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2025.107613_bib33","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1016\/j.vaccine.2006.12.024","article-title":"Identification of H-2d restricted Th epitopes in Urease B subunit of Helicobacter pylori","volume":"25","author":"Shi","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2025.107613_bib34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0022-1759(96)00071-3","article-title":"The application of epitope mapping in the development of a new serological test for Helicobacter pylori infection","volume":"194","author":"Burnie","year":"1996","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.micpath.2025.107613_bib35","first-page":"87","article-title":"Neutralizing antibodies for Helicobacter pylori urease inhibit bacterial colonization in the murine stomach in vivo, Biomedical Research","volume":"40","author":"Takeshita","year":"2019","journal-title":"Jpn. Times"},{"key":"10.1016\/j.micpath.2025.107613_bib36","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1007\/s00253-012-4486-1","article-title":"Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB\/c mice model","volume":"97","author":"Guo","year":"2013","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2025.107613_bib37","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.vaccine.2012.12.058","article-title":"Identification of two novel immunodominant UreB CD4(+) T cell epitopes in Helicobacter pylori infected subjects","volume":"31","author":"Yang","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2025.107613_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300085","article-title":"Synthetic self-adjuvanted lipopeptide vaccines conferred protection against Helicobacter pylori infection","volume":"12","author":"Xue","year":"2023","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.micpath.2025.107613_bib39","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3109\/08820138009066010","article-title":"Isolation of viral IgY antibodies from yolks of immunized hens","volume":"9","author":"Polson","year":"1980","journal-title":"Immunol. Commun."},{"key":"10.1016\/j.micpath.2025.107613_bib40","first-page":"1061","article-title":"Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter pylori infection","volume":"9","author":"Shin","year":"2002","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.micpath.2025.107613_bib41","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.micpath.2017.03.025","article-title":"In vitro evaluation of cross-strain inhibitory effects of IgY polyclonal antibody against H. pylori","volume":"110","author":"Solhi","year":"2017","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2025.107613_bib42","first-page":"243","article-title":"Diagnosis and treatment of Helicobacter pylori infections in children and elderly populations","volume":"5","author":"Peng","year":"2019","journal-title":"Chronic. Dis. Transl. Med."},{"key":"10.1016\/j.micpath.2025.107613_bib43","first-page":"58","article-title":"Medication adherence pattern and factors affecting adherence in Helicobacter pylori eradication therapy","volume":"14","author":"Shakya Shrestha","year":"2016","journal-title":"Kathmandu Univ. Med. J."},{"key":"10.1016\/j.micpath.2025.107613_bib44","article-title":"Helicobacter pylori and the human gastrointestinal microbiota: a multifaceted relationship","volume":"13","author":"Tohumcu","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.micpath.2025.107613_bib45","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","article-title":"Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in world Health organization regions","volume":"155","author":"Savoldi","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.micpath.2025.107613_bib46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5625\/lar.2012.28.1.55","article-title":"Anti-Helicobacter pylori effects of IgY from egg york of immunized hens","volume":"28","author":"Yang","year":"2012","journal-title":"Lab. Anim. Res."},{"key":"10.1016\/j.micpath.2025.107613_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106303","article-title":"The mechanisms of metronidazole resistance of Helicobacter pylori: a transcriptomic and biochemical study","volume":"183","author":"Huang","year":"2023","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2025.107613_bib48","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1128\/IAI.69.11.6597-6603.2001","article-title":"Identification of an antigenic epitope in Helicobacter pylori urease that induces neutralizing antibody production","volume":"69","author":"Hirota","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2025.107613_bib49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pep.2009.07.016","article-title":"Oral immunogenicity and protective efficacy in mice of a carrot-derived vaccine candidate expressing UreB subunit against Helicobacter pylori","volume":"69","author":"Zhang","year":"2010","journal-title":"Protein Expr. Purif."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025003389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025003389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T21:07:03Z","timestamp":1769202423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025003389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":49,"alternative-id":["S0882401025003389"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107613","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of the inhibitory effects of immunoglobulin Y antibody against key epitopes of Helicobacter pylori UreB recombinant protein","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107613"}}